Theranos: Elizabeth Holmes says investors were future-focused

- Advertisement -

Holmes, who faces nine counts of fraud and two counts of conspiracy, completed her defense in a US court on Wednesday.

- Advertisement -

Theranos founder Elizabeth Holmes finished testifying in her defense against the fraud charges Wednesday morning, telling jurors that investors were “not interested in today” but focused on the blood-testing startup’s impact in the long run. .


Holmes, 37, faces nine counts of fraud and two counts of conspiracy in a United States federal court for allegedly bringing in cash from wealthy private investors and patients paying for the test from the company about Theranos’ technology. to lie.

Holmes rose to fame in Silicon Valley for his ambitious drama of reintroducing blood testing with a device that supposedly could perform diagnostic analysis with the prick of a finger.

- Advertisement -

Once valued at $9bn, Theranos collapsed after The Wall Street Journal published a series of articles beginning in 2015 that suggested its tools were flawed and inaccurate.

Prosecutors allege that Holmes’ fraud involved false claims that Theranos’ equipment was able to run multiple tests more quickly and accurately than traditional laboratory tools.

During his final moments on the stand, Holmes said he sought to communicate the company’s future promise to long-term investors.

“I wanted to convey the impact the company has for people and healthcare,” Holmes said. “He was not interested in today, tomorrow or next month.”

Neither Holmes’ lawyers nor prosecutors called any more witnesses on Wednesday. Jury members will hear closing arguments at an unspecified date.

US District Judge Edward Davila said he needed time to hear the parties’ arguments about legal directions to be given to jurors, and that deliberations on the case could begin by the end of January, which is the jurors’ holiday. depends on the plan.


- Advertisement -
Mail Us For  DMCA / Credit  Notice

Recent Articles

Stay on top - Get the daily news in your inbox

Related Stories